A. Salamone

发表

Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.

M. Walker, E. Aronica, A. Vezzani, 2019, Brain : a journal of neurology.

Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy

Massimo Rizzi, Eleonora Aronica, Erwin A van Vliet, 2019, Brain : a journal of neurology.

Inhibition of monoacylglycerol lipase terminates diazepam‐resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet

A. Vezzani, L. Porcu, G. Terrone, 2018, Epilepsia.

High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy

A. Vezzani, D. Antoine, T. Ravizza, 2017, Brain, Behavior, and Immunity.

Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy

B. Abrahams, E. Aronica, M. During, 2022, Neurobiology of Disease.

Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome

V. Broccoli, P. D’Adamo, F. Ungaro, 2022, Nature Communications.

In vitro exposure to nicotine induces endocytosis of presynaptic AMPA receptors modulating dopamine release in rat nucleus accumbens nerve terminals

A. Pittaluga, C. Usai, A. Salamone, 2012, Neuropharmacology.

Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus

S. Govoni, A. Salamone, M. Grilli, 2012, Front. Pharmacol..

Inhibitory effects of beta-amyloid on the nicotinic receptors which stimulate glutamate release in rat hippocampus: the glial contribution.

S. Govoni, A. Salamone, M. Grilli, 2014, European journal of pharmacology.

Inflammation and Epilepsy: Preclinical Findings and Potential Clinical Translation.

A. Vezzani, G. Terrone, A. Salamone, 2017, Current pharmaceutical design.

Prolonged nicotine exposure down-regulates presynaptic NMDA receptors in dopaminergic terminals of the rat nucleus accumbens

Â. R. Tomé, P. Agostinho, A. Pittaluga, 2014, Neuropharmacology.

in dopaminergic terminals of the rat nucleus accumbens

Â. R. Tomé, R. Cunha, A. Pittaluga, 2013 .

Dual Effect of Beta-Amyloid on α7 and α4β2 Nicotinic Receptors Controlling the Release of Glutamate, Aspartate and GABA in Rat Hippocampus

C. Lanni, S. Govoni, A. Salamone, 2012, PloS one.

Changes of dimension of EEG/ECoG nonlinear dynamics predict epileptogenesis and therapy outcomes

W. Löscher, A. Vezzani, C. Brandt, 2019, Neurobiology of Disease.

Abstracts of the 6th Meeting of the Neapolitan Brain Group

Martine, Arianna, G. Fiorito, 2018, BMC Neuroscience.

Pre‐synaptic nicotinic receptors evoke endogenous glutamate and aspartate release from hippocampal synaptosomes by way of distinct coupling mechanisms

E. Fedele, A. Salamone, M. Grilli, 2010, British journal of pharmacology.

Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus

S. Govoni, A. Salamone, M. Grilli, 2011, Neurochemistry International.

Dangerous liaisons between beta-amyloid and cholinergic neurotransmission.

A. Pittaluga, C. Lanni, M. Racchi, 2014, Current pharmaceutical design.

Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus

S. Govoni, A. Salamone, M. Grilli, 2012, Front. Pharmacol..